DM

Showing posts with label After. Show all posts
Showing posts with label After. Show all posts

Sunday, August 18, 2013

Dad Dies After Drinking Poison in Assisted Living

George McAfee, a former running back for the Chicago Bears who developed dementia in his twilight years, died an excruciating and humiliating death in 2009 while in the care of an Atlanta assisted-living facility.

The pro-football Hall of Famer wandered unsupervised into a cleaning room and drank from a bottle of industrial-strength detergent. The caustic chemical burned his lips, esophagus and lungs before he died in the hospital, according to his family, which settled with the Emeritus Corporation, the company that ran the facility and took responsibility for his death.

When caregivers found McAfee, his lips were black and his face looked like a "horror show death mask," according to his daughter, Cheryl Morgan, 66, of Stone Mountain, Ga.

"It was horrible, horrible," she told ABCNews.com. "I cannot begin to tell you how horrific it was. We just hope he wasn't conscious."

Now, filmmaker A.C. Thompson of ProPublica, in collaboration with reporter Jonathan Jones and PBS' "Frontline," has taken a critical look at the for-profit world of assisted-living facilities. In addition to quasi-independent care, the facilities offer so-called "memory units" for families who want a safe and home-like environment for their loved ones who are suffering from dementia and Alzheimer's disease.

The facilities, sometimes with spiral staircases and lush grounds, are loosely regulated, depending on the state, and often don't have a full-time nurse on duty, according to the "Frontline" report, in contrast to nursing homes, which are federally funded and, therefore, under tougher scrutiny.

"Life and Death in Assisted Living" will air tonight at 10 p.m. ET.

"I realized that, in some ways, this is a secret world and people don't understand what's going on and the rules governing it," Thompson told ABCNews.com.

Conditions are difficult and workers are paid minimum wage, according to Thompson, who interviewed staff workers and elder care advocates.

"There is a high burn-out factor and people often don't last," said Thompson. "You get a revolving cast of caregivers.

For a lot of people without dementia, these facilities are great," he said. "They don't necessarily need a nurse to tend to them around the clock and they don't need an institutional setting.

"We met lots of compassionate, considerate, smart caregivers," he added. "My concern is that it's a loosely regulated industry and things can go traumatically wrong. The industry has an incredible emphasis on sales and revenue -- and making as much money as possible."

Researching consumer lawsuits and complaints in numerous facilities nationwide that led to injuries and death, Thompson cited inadequate staffing ratios, limited training and policies that put profit over patients' well-being.

One staffer said in the film that training consists of one eight-hour session on how to feed and talk to dementia patients.

Thompson examined numerous public files on assaults between residents, sexual assaults by caregivers and patients who went missing. One, according to the documentary, was never found.

Thompson alleged these units are marketing tools and "money makers."

The documentary focuses on one of the industry's leaders, Seattle-based Emeritus Corporation, whose advertising slogan is, "Our family is committed to yours."

Emeritus is the largest company in the assisted living business. It is publicly traded, with $1.6 billion in revenues a year, and is responsible for 42,000 residents at 480 facilities around the country.

"I adamantly disagree that we put profits ahead of service care," Granger Cobb, president and CEO of Emeritus, told ABCNews.com.

"Senior living is a highly competitive industry," he said. "It's a very emotional time when a family considers many assisted living options and they reach out to friends and family and physicians and clergymen and ask for referrals.

Having a strong reputation is critical. Otherwise, we don't last very long. I don't think a company would ever sacrifice that reputation and customer satisfaction for some short-term gain on bottom line."

But McAfee's family sued Emeritus, which settled out of court. Facility records eventually revealed that for a half hour no one was on duty in the wing where McAfee found the cleaning fluid.

Cobb acknowledged an Emeritus staff member failed to lock the cabinet -- "a failure on our part."

"George McAfee was an absolute tragic accident that was horrific and the community was devastated," he said. "We sincerely regret the pain and trauma they experienced. … There has never been a similar accident in 20 years since we were founded."

Thompson's year-long investigation also uncovered the case of a Texas woman who froze to death on Christmas day in 2004. Her family sued Emeritus and settled confidentially. He also found several cases of patients falling to their deaths at Emeritus facilities.

"When dealing with this many residents, particularly a population that can have unpredictable behavior or is frail or high-risk to begin with, we will have a situation with them from time to time," he said.

In the next 15 years, the number of Americans who are 70 and older will grow by 1 million annually, Cobb noted in the film.

"Memory units are an ideal choice for those who are memory impaired but who don't have intense medical needs," he said. "The environment feels more normal and home-like to them."

"Frontline" noted that because of their age, most residents in this age group are on multiple medications -- often 10 to 15 a day -- and said lack of medical services and understaffing can lead to mistakes.

The film cited one incident when only one employee was on staff at night.

But Emeritus' Cobb said that, "generally speaking," company facilities have at least three staff members on a night -- two caregivers and a med tech.

In the documentary, former Emeritus staff members and nurses at numerous facilities described a "back-door" policy, saying that they were encouraged not to let patients leave these units for nursing homes to keep beds full.

"Generally, families want to keep their loved ones with us as long as possible and defer moving to skilled nursing," said Cobb. "If a resident requires skilled nursing, we work with the family to arrange as quickly and smoothly as possible."

McAfee was at several other facilities before coming to Cypress Gardens near his daughter, Morgan, in Georgia in 2006. The fee was $4,000 a month -- "a lot of money," she said.

The family thought they had "struck gold" -- a far cry from the sterile corridors of a nursing home where they saw patients sit listless in wheelchairs.

But when Emeritus took over the facility shortly thereafter, "it went down from there," said Morgan, alleging his sheets were never changed, the room and he were rarely cleaned and he "looked like a dirty old man."

At first, her father had regular caregivers who knew his tendency to be obstinate and to wander. But soon, Emeritus began to rotate staff, according to Morgan.

"He was a wanderer and he couldn't sleep," she said.

You are using an outdated version of Internet Explorer. Please click here to upgrade your browser in order to comment.

View the original article here

Saturday, August 17, 2013

Girl Dies After Allergic Reaction to Camp Treat

A California teen has died from a severe allergic reaction after accidentally biting into a camp treat made with peanut butter.

Natalie Giorgi, 13, was vacationing with her family at Camp Sacramento in California's Eldorado National Forest Friday when she grabbed a crispy rice treat off of a dessert tray at the campsite, ABC affiliate KXTV reported. It was dark, and Natalie failed to realize that the treat had been made with peanut butter before taking a bite.

"She took every care," Pastor Michael Kiernan of Our Lady of the Assumption Church in Natalie's hometown of Carmichael, Calif., told KXTV, bewildered by the unexpected death of a seventh-grader who was well aware of her deadly allergy. "They were really on it all the time."

See the 17 scariest allergy triggers.

Natalie quickly spit out the mouthful and alerted her mom, but it was too late. Within 20 minutes, the teen began vomiting and had difficulty breathing, a family friend told KXTV.

"A small amount of peanut, if you're a sensitive person, can be fatal," said Dr. Scott Sicherer, professor of pediatrics and chief of the division of allergy and immunology at the Mount Sinai School of Medicine in New York City. "And peanut is a pretty common food, which can be hidden in things, so it's hard to avoid."

Three epinephrine autoinjectors were used in an effort to quell the full-body allergic reaction, according to the family friend, but Natalie went into cardiac arrest. She was rushed to the nearest hospital by ambulance but pronounced dead upon arrival.

"While our hearts are breaking over the tragic loss of our beautiful daughter Natalie, it is our hope that others can learn from this and realize that nut and food allergies are life threatening," Natalie's family said in a statement to KXTV. "Caution and care for those inflicted should always be supported and taken."

Read about how a college freshman died after eating a cookie baked with peanut oil.

One in 20 U.S. children has a food allergy, according to the U.S. Centers for Disease Control and Prevention. Peanuts are among the most common food allergens, which also include cow's milk, eggs, tree nuts, fish, shellfish, soybeans and wheat. Peanuts are also one of the deadliest food allergens, according to Sicherer.

"Teenagers and young adults seem to be the ones at the highest risk for fatal reactions," he said, noting that a delay in injecting epinephrine can often factor into the tragic outcome. "One of the common themes among children and adults who had fatal reactions is they didn't use the medication in the beginning. And by the time you develop serious symptoms, it can be too late."

Children and teenagers can underestimate the seriousness of the early signs of anaphylaxis, such as itching in mouth and throat, according to Dr. Stanley Fineman, an allergist with the Atlanta Allergy and Asthma clinic and the immediate past president of the American College of Allergy, Asthma and Immunology.

"Some people just report 'feeling funny,'" Fineman added, noting that it's better to be safe than sorry in the early stages of a severe allergic reaction. "If you think you might need to use epinephrine, go ahead and use it. You're better off taking it and not needing it than not taking it and needing it."

Neither Fineman nor Sicherer know the details of Natalie's reaction or the emergency response.

Calls to Camp Sacramento, where the Giorgi had vacationed for the past four summers, were not immediately returned. It's unclear whether the treats were provided by the camp or brought by other campers.

You are using an outdated version of Internet Explorer. Please click here to upgrade your browser in order to comment.

View the original article here

Tuesday, July 23, 2013

Life After a Face Transplant

After hiding his face for 15 years, Richard Lee Norris has stepped into the spotlight for a book about the surgery that saved his life.

Norris made headlines in 2012 when he received a full face transplant – the result of a 36-hour operation that swapped his scarred skin and shattered bones with tissue from a donor. Now he's sharing his story in "The Two Faces of Richard," a biography punctuated with never-before-seen black and white photos of his amazing transformation.

"This book shows that it's possible to go through hell and come out on the other side," said Coos Hamburger, a photojournalist and author of the e-book recently released on Amazon.

See pictures of Richard Lee Norris and other face transplant recipients through the years.

The story begins on Sept. 10, 1997, when the Remington 12-gauge pump shotgun Norris was repositioning in a gun cabinet emptied a round in his face.

"Richard's memory of the details was virtually obliterated along with his chin, jaws, mouth, nose and tongue," Coos wrote in his book, describing the horrific accident that landed Norris in a medically-induced coma as doctors raced to save his life and salvage remnants of his face. "He recalls only a vague fog of thoughts tied together like a cobweb as he gradually recovered in the hospital weeks later."

When Norris awoke from a series of surgeries to repair the near-fatal damage, he couldn't believe what he saw.

"The high ballistic shot had removed everything from just at the center of my eyes to the bottom of my chin," Norris recalled in the book. "For the longest time I didn't even want to see what my face looked like. I didn't want to feel it nor even have people see me look that way."

Read about the evolution of face transplants.

Norris said he "fell into a recluse state," admitting in the book he sometimes felt like suicide was "the best option."

"I would always walk with my head held low, my face covered up with a surgical mask, trying to hide from the world," he recalled. "I only shopped at places where I knew the people who worked there or I would go late at night when there were fewer people around."

"The best part of my day was when I was asleep and living in a normal world," he added.

Hamburger met Norris in 2011 while working on a book about shock trauma at the University of Maryland Medical Center.

"I remember him asking why anyone would want to share the most difficult moment of their life," Hamburger said of an early encounter with Norris. "I said every person comes at it from a slightly different perspective, but many people are motivated to share their story so that someone else doesn't have to endure what they did."

Norris, who had "virtually no photographs" of himself from after the accident, agreed to let Hamburger document his struggle amid the looming prospect of a face transplant – a pioneering procedure fraught with risks.

"I remember standing with Richard in the lobby of a hotel, and there was a couple with a young child checking out. The girl peered around the corner just as Rich was in the process of changing his mask, and she was just petrified," Hamburger said. "I could see how much that hurt him. It was really the first time I got a sense of why he'd gotten to the point of considering a transplant with all its risks, including death. Living the way he did, in many ways, was untenable."

You are using an outdated version of Internet Explorer. Please click here to upgrade your browser in order to comment.

View the original article here

Tuesday, May 21, 2013

Geoscientist Leuren Moret Became Environmental Whistleblower After Yucca Mountain Project

By JG Vibes
February 28, 2013

Tonight on the Bob Tuskin Radio Show we will be covering some of the days top headlines from around the world.

Also be sure to catch tonight’s guest, Leuren Moret.

Click here to listen live at 10PM-11PM eastern standard time on February 28, 2013

Leuren Moret is a geoscientist who has worked around the world on radiation issues, educating citizens, the media, members of parliaments, Congress, and other officials. She became a whistleblower in 1991 at the Livermore Nuclear Weapons Lab after experiencing major science fraud on the Yucca Mountain Project. Leuren is an environmental commissioner in the city of Berkeley, CA.

Leuren Moret will also be appearing at this years Free Your Mind 2 Conference in Philadelphia this April.

Check out the Free Your Mind Conference Here

This conference is a three-day conference featuring top-calibre whistle-blowers from across the country who will shed light upon our world’s problems and bring forward empowering solutions.

Bob Tuskin and JG Vibes of theintelhub.com will also be appearing at this years FYM 2 Conference as will dozens of speakers, authors and researchers.

Check out one of Leuren Moret’s videos below:

*****
Read more articles by this author HERE.

J.G. Vibes is the author of an 87 chapter counter-culture textbook called Alchemy of the Modern Renaissance, a staff writer, reporter for theintelhub.com and Executive Producer of the Bob Tuskin Radio Show.

You can keep up with his work, which includes free podcasts, free e-books & free audiobooks at his website www.aotmr.com

Copyright c 2011 BobTuskin.com All Rights Reserved - Health statements, opinions, and products that appear on BobTuskin.com have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease. Nothing on this website or radio show should be considered medical advice.

FAIR USE NOTICE. Many of the stories on this site contain copyrighted material whose use has not been specifically authorized by the copyright owner. We are making this material available in an effort to advance the understanding of environmental issues, human rights, economic and political democracy, and issues of social justice. We believe this constitutes a 'fair use' of the copyrighted material as provided for in Section 107 of the US Copyright Law which contains a list of the various purposes for which the reproduction of a particular work may be considered fair, such as criticism, comment, news reporting, teaching, scholarship, and research. If you wish to use such copyrighted material for purposes of your own that go beyond 'fair use'...you must obtain permission from the copyright owner.

If you believe we have infringed your copyright please email us here and we will respond within 24 hours.


View the original article here

Saturday, May 18, 2013

Chemotherapy Effective Whether Given Before or After Breast Cancer Surgery

Giving chemotherapy before breast-conserving surgery is as effective against breast cancer recurrence as giving chemotherapy after breast-conserving surgery. These results were presented at the 2011 Breast Cancer Symposium.?

Breast-conserving surgery (also referred to as lumpectomy) involves removal of the breast cancer and some surrounding normal tissue. For some women, giving chemotherapy prior to surgery can shrink the cancer and make it easier to remove. There’s been some uncertainty, however, about whether chemotherapy followed by breast-conserving surgery is as effective against local-regional recurrence (cancer recurrence in or near the breast) as breast-conserving surgery followed by chemotherapy.?????

To evaluate whether risk of breast cancer recurrence varies by timing of chemotherapy, researchers collected information about roughly 3,000 women who underwent breast-conserving surgery and radiation therapy between 1987 and 2005. Roughly three-quarters of the patients underwent surgery first and the remaining patients underwent chemotherapy first. Women who received chemotherapy first tended to have cancers with worse prognostic features.????

Factors that were linked with an increased risk of breast cancer recurrence were young age (less than 50 years), clinical stage III cancer, grade 3 cancer, cancer that was estrogen receptor-negative, and close or positive surgical margins (cancer at or near the edge of the tissue that was surgically removed).?After accounting for tumor characteristics, risk of breast cancer recurrence was similar among women who underwent surgery first and women who underwent chemotherapy first.?

These results suggest that tumor characteristics—rather than the timing of chemotherapy—influence risk of breast cancer recurrence.?????

Reference: Mittendorf EA, Buchholz TA, Tucker SL et al. Impact of chemotherapy timing on local-regional failures in patients with breast cancer undergoing breast-conserving therapy. Paper presented at: 2011 Breast Cancer Symposium; September 8-10, 2011; San Francisco, CA. Abstract 82.?

Posted September 12, 2011


View the original article here

Pregnancy After Breast Cancer Appears to Be Safe

A study of young women found that pregnancy after a diagnosis of estrogen receptor-positive breast cancer does not appear to increase the risk of cancer recurrence. These results were presented at the eighth European Breast Cancer Conference.?????

Breast cancer is the most common type of cancer among women of childbearing age. For women who develop breast cancer before completing their families, many questions arise about fertility preservation and the safety of a subsequent pregnancy. In the case of estrogen receptor-positive breast cancer, there has been some uncertainty about whether the hormonal changes of pregnancy could increase the risk of cancer recurrence.??

To explore whether pregnancy affects risk of breast cancer recurrence, researchers from several countries conducted a study among 333 women who had become pregnant after a diagnosis of breast cancer, and 874 similar women who did not become pregnant. ?

The women aged in range from 21 to 48 (average age was 34).??

Recurrence risk was similar in the women who did and did not become pregnant. This was true for women with estrogen receptor-positive breast cancer and for women with estrogen receptor-negative breast cancer. ?In the subset of women who became pregnant soon after their breast cancer diagnosis (within two years), risk of recurrence was actually somewhat lower than in the women who did not become pregnant. The researchers recommend caution in interpreting this result, noting “pregnancy within two years of diagnosis should be regarded as safe, and not as protective.”?Miscarriage, abortion, and breastfeeding did not appear to affect breast cancer outcome.??

Although this study does not provide definitive proof of the safety of pregnancy after breast cancer, these results should be reassuring to women who wish to become pregnant after a breast cancer diagnosis.?????

Because some types of cancer treatment can affect a woman’s fertility, women who are interested in becoming pregnant should discuss the issue of fertility preservation with their physician before cancer treatment begins.????

Reference: Azim Jr H, Kroman N, Ameye L et al. Pregnancy following estrogen receptor-positive breast cancer is safe – results from a large multi-center case-control study. Paper presented at: eighth European Breast Cancer Conference (EBCC8); March 21-24, 2012;? Vienna, Austria. Abstract 21. ?

Posted March 30, 2012


View the original article here

Friday, May 17, 2013

Breast Cancer Risk after False-Positive Screening Results

Women with false-positive test results for breast cancer may want to remain vigilant with screening, as false-positive results could be associated with underlying pathology that may result in breast cancer, according to the results of a study published in the Journal of the National Cancer Institute.[1]???

A mammogram is an X-ray of the breast. Screening mammography is performed in a woman without breast symptoms in order to detect breast cancer at an early stage when it is most easily treated. Different groups of experts have reached different conclusions about when mammographic screening should begin and how often it should be performed. The U.S. Preventive Services Task Force recommends that routine screening of average-risk women begin at age 50 and be performed every two years. The American Cancer Society recommends annual screening beginning at age 40.?

Although screening mammography can reduce the risk of death from breast cancer (due to early detection), disease screening in healthy individuals can also lead to false-positive test results. A false-positive result suggests that cancer may be present even though the person is actually cancer-free. False-positive results can lead to anxiety and unnecessary additional testing.?

Women with false-positive mammography results are usually referred back for routine screening; however, it is unknown whether these women have a higher long-term risk for breast cancer compared to women who initially test negative. ?

In order to determine if women with false-positive mammography results have a higher risk of developing breast cancer than those who test negative, researchers from the University of Copenhagen evaluated data from a population-based mammography program in Copenhagen, Denmark from 1991-2005. They used the data to measure the risk of breast cancer and ductal carcinoma in situ (DCIS) in 58,003 women between the ages of 50-69 who had received false-positive test results. ?

The results indicated that women who had tested negative for breast cancer had an absolute cancer rate of 339 per 100,000 person-years at risk, whereas women had tested false-positive had an absolute rate of 583 per 100?000 person-years at risk. Six or more years after the test, the relative risk of breast cancer in women with false-positive results was statistically significantly higher than women who tested negative; however, those statistics lowered when new screening technology was introduced in the year 2000. ?

It’s important for women to discuss screening options with their physician in order to determine their optimal screening protocol for breast cancer. Based on the results of this study, women with false-positive mammography results may benefit from close monitoring and continued regular screening.?????

Reference:?


[1] Euler-Chelpin MV, Risor LM, Thorsted BL, et al. Risk of breast dancer after false-positive test results in screening mammography. Journal of the National Cancer Institute. Published early online April 5, 2012: doi: 10.1093/jnci/djs176?

View the original article here

Tuesday, May 14, 2013

Hormone Replacement Therapy after Ovary Removal May be Safe for BRCA1/BRCA2 Carriers

For women with BRCA1 or BRCA2 gene mutations, use of hormone replacement therapy after preventive removal of the ovaries and fallopian tubes does not appear to increase the risk of breast cancer. These results were presented at the 2011 annual meeting of the American Society of Clinical Oncology.???

Inherited mutations in two genes—BRCA1 and BRCA2—have been found to greatly increase the lifetime risk of developing breast and ovarian cancer. Mutations in these genes can be passed down through either the mother’s or the father’s side of the family.??

Options to manage this increased cancer risk include regular cancer screening, chemoprevention (use of medications to reduce risk), or preventive surgery (surgery to remove the breasts and/or ovaries before cancer is diagnosed).?

When performed by the time a woman is in her mid-30s or early 40s, preventive removal of the ovaries can substantially reduce the risk of both ovarian cancer and breast cancer. This reduction in cancer risk, however, comes at the cost of an early menopause and symptoms such as hot flashes, sleep disturbances, and vaginal dryness.??

Hormone replacement therapy (HRT) can effectively manage these symptoms, but it’s been uncertain whether this is safe for women with BRCA1/BRCA2 mutations. Studies in women without these mutations have indicated the combined (estrogen plus progestin) hormone therapy increases the risk of breast cancer.?

To evaluate the risk of breast cancer among BRCA1/BRCA2 carriers who have undergone preventive removal of their ovaries and fallopian tubes, researchers collected information from 795 women with a BRCA1 mutation and 504 women with a BRCA2 mutation. ?

????After ovary removal, breast cancer was diagnosed in 14% of the women who took HRT and 12% of the women who did not take HRT. This difference between groups was not statistically significant, suggesting that it could have occurred by chance alone. By comparison, risk of breast cancer was 22% among women who did not have their ovaries removed and did not take HRT.??

These results suggest that short-term use of HRT to manage menopausal symptoms may be an option for BRCA1/BRCA2 carriers who have had their ovaries removed. HRT did not significantly increase the risk of breast cancer in this population.????

Reference: Domchek SM, Friebl T, Neuhausen SL et al. Is hormone replacement therapy (HRT) following risk-reducing salpingo-oophorectomy (RRSO) in BRCA1 (B1) and BRCA2 (B2)-mutation carriers associated with an increased risk of breast cancer? Paper presented at: 2011 Annual Meeting of the American Society of Clinical Oncology; June 3-7, 2011; Chicago, IL. Abstract 1501.?


View the original article here

Monday, May 13, 2013

Fatigue After Breast Cancer Treatment May Fade Over Time

Cancer-related fatigue (CRF) is common after treatment for early stage breast cancer, but new results indicate that the phenomenon fades over time, according to a study published in the Journal of Clinical Oncology.?

Breast cancer is the most commonly diagnosed type of cancer (other than skin cancer) in US women. Each year, roughly 227,000 women are diagnosed with breast cancer and close to 40,000 die of the disease. Treatment of early breast cancer may include breast-conserving surgery, radiation, and (when appropriate) systemic therapies such as chemotherapy and hormonal therapy.?

After treatment, some survivors experience long-term adverse effects, including prolonged, disabling fatigue—referred to as cancer-related fatigue or CRF. There is no clear understanding of the underlying causes of CRF and there are no effective prevention or treatment strategies.??

Researchers from Australia studied CRF in a cohort of 218 women who received some sort of adjuvant treatment for early breast cancer. The women were enrolled in the study after surgery and were observed at 1, 3, 6, 9, and 12 months as well as 5 years. At each interval, the women underwent structured interviews and responded to questionnaires about their physical and psychological health. ?

Immediately after treatment, 31% of women experienced CRF; however, the rate of CRF dropped to 11% six months after treatment and 6% one year after treatment. Women who were still experiencing persistent fatigue after six months were evaluated to rule out other causes such as low thyroid levels or depression.?

The researchers noted that CRF was associated with significant disability and healthcare utilization. It was not clear why some women remained fatigued for months after treatment. There is speculation that inflammation could be a factor or that some patients may have a genetic predisposition that creates an exaggerated response to chemotherapy. As of yet, there is no data to support these theories. ?

The researchers concluded that CRF is common among women treated for early breast cancer, but generally fades over time. Women who suffer from CRF might benefit from following a healthy diet and getting regular exercise and sleep. ????

Reference:?

Goldstein D, Bennett BK, Webber K, et al. Cancer-related fatigue in women with breast cancer: outcomes of a 5-year prospective cohort study. Journal of Clinical Oncology. Published early online: April 16, 2012. doi:10.1200/JCO.2011.34.6148?

Posted?May 3, 2012?


View the original article here